Literature DB >> 30834697

Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP?

Naveen L Pereira1,2, Viral K Desai2, Allan S Jaffe3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30834697      PMCID： PMC6508995          DOI： 10.1002/ejhf.1451

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  22 in total

1.  Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.

Authors:  Luis Miguel Ruilope; Andrej Dukat; Michael Böhm; Yves Lacourcière; Jianjian Gong; Martin P Lefkowitz
Journal:  Lancet       Date:  2010-03-16       Impact factor: 79.321

2.  Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.

Authors:  Nicolas Vodovar; Marie-France Séronde; Said Laribi; Etienne Gayat; Johan Lassus; Riadh Boukef; Semir Nouira; Philippe Manivet; Jane-Lise Samuel; Damien Logeart; Shiro Ishihara; Alain Cohen Solal; James L Januzzi; A Mark Richards; Jean-Marie Launay; Alexandre Mebazaa
Journal:  Eur Heart J       Date:  2014-08-24       Impact factor: 29.983

3.  Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure.

Authors:  Jens Fielitz; Andreas Dendorfer; Reinhard Pregla; Elisabeth Ehler; Heinz R Zurbrügg; Jozef Bartunek; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

4.  Increased expression of renal neutral endopeptidase in severe heart failure.

Authors:  Mathias Knecht; Ines Pagel; Thomas Langenickel; Sebastian Philipp; Michaela Scheuermann-Freestone; Thomas Willnow; Dennis Bruemmer; Kristof Graf; Rainer Dietz; Roland Willenbrock
Journal:  Life Sci       Date:  2002-10-25       Impact factor: 5.037

5.  Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation.

Authors:  Naveen L Pereira; Pinar Aksoy; Irene Moon; Yi Peng; Margaret M Redfield; John C Burnett; Eric D Wieben; Vivien C Yee; Richard M Weinshilboum
Journal:  J Mol Cell Cardiol       Date:  2010-08-06       Impact factor: 5.000

6.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

7.  Circulating angiotensin II levels under repeated administration of lisinopril in normal subjects.

Authors:  M Kawamura; M Imanashi; Y Matsushima; K Ito; K Hiramori
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-08       Impact factor: 2.557

8.  Immunodetection of glycosylated NT-proBNP circulating in human blood.

Authors:  Karina R Seferian; Natalia N Tamm; Alexander G Semenov; Anastasia A Tolstaya; Ekaterina V Koshkina; Mihail I Krasnoselsky; Alexander B Postnikov; Daria V Serebryanaya; Fred S Apple; MaryAnn M Murakami; Alexey G Katrukha
Journal:  Clin Chem       Date:  2008-03-13       Impact factor: 8.327

Review 9.  Cardioprotective effect of adrenomedullin in heart failure.

Authors:  Toshio Nishikimi; Fumiki Yoshihara; Yosuke Mori; Kenji Kangawa; Hiroaki Matsuoka
Journal:  Hypertens Res       Date:  2003-02       Impact factor: 3.872

10.  Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves.

Authors:  Satu Helske; Mika Laine; Markku Kupari; Jyri Lommi; Heikki Turto; Laura Nurmi; Ilkka Tikkanen; Kalervo Werkkala; Ken A Lindstedt; Petri T Kovanen
Journal:  Eur Heart J       Date:  2007-05-15       Impact factor: 29.983
View more
  1 in total

Review 1.  B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?

Authors:  Toshio Nishikimi; Yasuaki Nakagawa
Journal:  Biology (Basel)       Date:  2022-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.